Search Within

Madhavi Tadi

  1. "Eric Joseph"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Breast Medicine Service (6)
  2. Department of Medicine (6)
  3. GSK Faculty (6)
  4. Molecular Pharmacology and Chemistry Program Faculty (6)
  5. Sloan Kettering Institute Faculty (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Christine Pratilas (6)
  2. Eric Joseph (6)
  3. Neal Rosen (6)
  4. Poulikos Poulikakos (5)
  5. Elisa De Stanchina (4)
  6. Piro Lito (3)

More People

Years
  1. 2013 (1)
  2. 2012 (2)
  3. 2011 (1)
  4. 2010 (2)
Publications
  1. Cancer Research (4)
  2. Cancer Cell (1)
  3. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Association for Cancer Research (4)
  2. Cell Press (1)
  3. National Academy of Sciences (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Feedback dependent suppression of mitogenic signaling and its effect on RAF inhibition in BRAFV600E melanomas
    Meeting Abstract

    Lito, P.; Pratilas, C.; Joseph, E.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; de Stanchina, E.; Chandarlapaty, S.; Poulikakos, P.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of RTK and RAS signaling in V600E BRAF melanomas exposed to RAF inhibitors buffers their effects on signaling
    Meeting Abstract

    Pratilas, C. A.; Joseph, E. W.; Tadi, M.; Poulikakos, P. I.; Gabay, M.; Lito, P.; Wong, W.; DeStanchina, E.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas
    Journal Article

    Lito, P.; Pratilas, C. A.; Joseph, E. W.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; Wong, W. L.; Callahan, M. K.; Merghoub, T.; more...
    Cancer Cell (2012)

    Fulltext@MSK | Save
  • MEK inhibitors prevent rebound reactivation of ERK signaling by the RAF inhibitor PLX4032 and enhance its antitumor activity
    Meeting Abstract

    Pratilas, C. A.; Joseph, E. W.; Tadi, M.; Gabay, M.; Wong, W.; De Stanchina, E.; Bollag, G.; Rosen, N.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • The pan-RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF mutant-selective manner
    Meeting Abstract

    Joseph, E. W.; Pratilas, C. A.; Poulikakos, P. I.; Tadi, M.; Wang, W.; Taylor, B. S.; Persaud, Y.; Xing, F.; Halilovic, E.; Viale, A.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
    Journal Article

    Joseph, E. W.; Pratilas, C. A.; Poulikakos, P. I.; Tadi, M.; Wang, W.; Taylor, B. S.; Halilovic, E.; Persaud, Y.; Xing, F.; Viale, A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save